BiPAP for Cardiomyopathy With Central Sleep Apnea

Nagoya University

Overview

We investigated whether treatment of central sleep apnea-hypopnea with bilevel positive airway pressure (BiPAP) in patients with idiopathic dilated cardiomyopathy (IDCM) would improve LV function.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Dilated Cardiomyopathy

Interventions

bilevel positive airway pressureDEVICE

bilevel positive airway pressure (Device)DEVICE

Eligibility

Sex: ALLMin age: 20 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Idiopathic dilated cardiomyopathy Exclusion Criteria: * a history of alcohol abuse, diabetes mellitus, endocrine disorders, hypertension, obstructive sleep apnea syndrome, and chronic obstructive pulmonary disease

Locations (1)

Nagoya University of Health Sciences

Nagoya, Japan

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.